Back to chapter

24.3:

์ฒด์•ก์„ฑ ๋ฉด์—ญ ๋ฐ˜์‘

JoVE Core
Biology
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Core Biology
Humoral Immune Responses

Languages

Share

– [๊ฐ•์‚ฌ] ๋‹ค๋ฅธ ์ ์‘ ๋ฉด์—ญ ๋ฐ˜์‘์—์„œ์ฒด์•ก ๋ฉด์—ญ์€ ๋ฉด์—ญ๊ณ„๊ฐ€ ์‚ผ๋Š” ํ‘œ์ ์ด ๋ณ‘์›์ฒด๋กœ์„œ์„ธํฌ ์™ธ์•ก ์ˆœํ™˜ํ•˜๊ณ  ์žˆ๋Š” ๊ฒƒ์ธ๋ฐํ˜ˆ์•ก๊ณผ ๋ฆผํ”„๊ฐ€ ํฌํ•จ๋ฉ๋‹ˆ๋‹ค๋ฐ•ํ…Œ๋ฆฌ์•„์™€ ๊ฐ™์€ ๋ณ‘์›๊ท ์˜ ์นจ์ž…์€ํŠน์ • ๋ฐฑํ˜ˆ๊ตฌ์ธ B ์„ธํฌ๊ฐ€ ๊ฐ์ง€ํ•˜๋Š”๋ฐ๋ฐ•ํ…Œ๋ฆฌ์•„ ํ‘œ๋ฉด์˜ ํŠน์ • ํ•ญ์›์„ ์ธ์‹ํ•ฉ๋‹ˆ๋‹ค์ผ๋‹จ B ์„ธํฌ๊ฐ€ ํ™œ์„ฑํ™”๋˜๋ฉด์ฆ์‹์„ ํ†ตํ•ด ์›ํ˜•์งˆ ์„ธํฌ๋กœ ๋ถ„ํ™”ํ•˜๋ฉฐ์ˆ˜๋ฐฑ๋งŒ ๊ฐœ์˜ ํ•ญ์ฒด๋ฅผ ๋ถ„๋น„ํ•ฉ๋‹ˆ๋‹ค์ด๋“ค์€ ๋ชธ ์ „์ฒด์— ์—ฌ๋Ÿฌ ๋ฐฉ์–ด ๋ฉ”์ปค๋‹ˆ์ฆ˜์„ ํ™œ์„ฑํ™”์‹œํ‚ต๋‹ˆ๋‹คํ•œ ๊ฐ€์ง€ ๋ฐฉ๋ฒ•์œผ๋กœ, ๋ณ‘์›์ฒด ํ‘œ๋ฉด์— ํ•ญ์›์„ ๊ฒฐํ•ฉํ•˜๋Š” ํ•ญ์ฒด๋Š”๋ณ‘์›์ฒด๋ฅผ ๋น„ํ™œ์„ฑํ™” ๋˜๋Š” ์ค‘ํ™”์‹œํ‚ฌ ์ˆ˜ ์žˆ์œผ๋ฉฐ์ˆ™์ฃผ ์„ธํฌ์— ๋Œ€ํ•œ ๊ฐ์—ผ ๋Šฅ๋ ฅ์„ ๋ฐฉํ•ดํ•˜๋ฉฐ ์ผ์–ด๋‚ฉ๋‹ˆ๋‹ค๋˜ํ•œ ๋ณ‘์›๊ท ์„ ์˜ต์†Œ๋‹Œํ•˜๊ฑฐ๋‚˜ ํƒœ๊ทธํ•˜์—ฌ์‹์„ธํฌ์— ์˜ํ•œ ํก์ž…๊ณผ ํŒŒ๊ดด๊ฐ€ ์ด์–ด์ง€๋ฉฐ๋Œ€์‹ ์„ธํฌ ๋˜๋Š” ํ˜ธ์ค‘๊ตฌ๊ฐ€ ํ•ด๋‹น๋ฉ๋‹ˆ๋‹ค๋งˆ์ง€๋ง‰์œผ๋กœ, ํ•ญ์ฒด๋Š” ๋ณด์ฒด๊ณ„๋ฅผ ํ™œ์„ฑํ™”์‹œํ‚ค๋ฉฐ์ด๋Š” ๋‹จ๋ฐฑ์งˆ์˜ ๋ณตํ•ฉ์ฒด๋กœ์„œ๋ณ‘์›๊ท ์˜ ์˜ต์†Œ๋‹Œ ๊ณผ์ •๊ณผ ํŒŒ๊ดด๋ฅผ ํ•œ์ธต ๊ฐ•ํ™”์‹œํ‚ต๋‹ˆ๋‹ค๋ณ‘์›๊ท ์ด ํŒŒ๊ดด๋˜๋”๋ผ๋„์ผ๋ถ€ ํ™œ์„ฑํ™”๋œ B ์„ธํฌ๋Š”์›ํ˜•์งˆ ์„ธํฌ ๋Œ€์‹ ์— ๊ธฐ์–ต B ์„ธํฌ๋กœ ๋ณ€ํ•ฉ๋‹ˆ๋‹ค์ด๋Ÿฌํ•œ ๊ธฐ์–ต B ์„ธํฌ๋Š” ๊ณ„์†ํ•ด์„œ๊ฐ์—ผ์ด ์‚ฌ๋ผ์ง„์ง€ ์˜ค๋ž˜๋ผ๋„ ์†Œ๋Ÿ‰์˜ ํ•ญ์ฒด๋ฅผ ์ƒ์‚ฐํ•ฉ๋‹ˆ๋‹ค๋งŒ์•ฝ ๋™์ผ ๋ณ‘์›์ฒด๊ฐ€ ๋ชธ์— ์ง„์ž…ํ•˜๋ฉด์ด๋Ÿฌํ•œ ์ˆœํ™˜ ํ•ญ์ฒด์˜ ํ‘œ์ ์ด ๋˜์–ด์ฆ‰๊ฐ์ ์ธ ํŒŒ๊ดด๋ฅผ ๋‹จํ–‰ํ•ฉ๋‹ˆ๋‹ค

24.3:

์ฒด์•ก์„ฑ ๋ฉด์—ญ ๋ฐ˜์‘

๊ฐœ์š”

ํ•ญ์ฒด ๋งค๊ฐœ ๋ฉด์—ญ ๋ฐ˜์‘(antibody-mediated immune response)์ด๋ผ๊ณ ๋„ ์•Œ๋ ค์ง„ ์ฒด์•ก์„ฑ ๋ฉด์—ญ ๋ฐ˜์‘(humoral immune response)์€ “์ฒด์•ก(humor)”, ์ฆ‰ ํ˜ˆ์•ก๊ณผ ๋ฆผํ”„(lymph)์™€ ๊ฐ™์€ ์„ธํฌ์™ธ์•ก(extracellular fluid)๋ฅผ ํ†ตํ•ด ์ˆœํ™˜ํ•˜๋Š” ๋ณ‘์›์ฒด๋ฅผ ๋Œ€์ƒ์œผ๋กœ ํ•ฉ๋‹ˆ๋‹ค. ํ•ญ์ฒด(antibody)๋Š” ์ค‘ํ™”(neutralization), ์˜ต์†Œ๋‹Œํ™”(opsonization), ๋ณด์ฒดํ™œ์„ฑํ™”(complement activation)๋ฅผ ํฌํ•จํ•œ ์—ฌ๋Ÿฌ ๋ฐฉ์–ด ๊ธฐ์ž‘์„ ํ†ตํ•ด ์นจ์ž…ํ•œ ๋ณ‘์›์ฒด๋ฅผ ํŒŒ๊ดดํ•˜๋Š” ๊ฒƒ์„ ๋ชฉํ‘œ๋กœ ํ•ฉ๋‹ˆ๋‹ค. ํ•ญ์ฒด ์ƒ์‚ฐ์ด ์ €ํ•˜๋œ ํ™˜์ž๋Š” ์ผ๋ฐ˜ ๋ณ‘์›์ฒด์™€ ํ”์น˜ ์•Š์€ ๋ณ‘์›์ฒด์— ์˜ํ•œ ์‹ฌ๊ฐํ•˜๊ณ  ๋นˆ๋ฒˆํ•œ ๊ฐ์—ผ์„ ๊ฒช์Šต๋‹ˆ๋‹ค.

B ์„ธํฌ๋Š” ๊ณจ์ˆ˜์— ์˜ํ•ด ์ƒ์„ฑ๋˜๊ณ  ์ฒด์•ก์„ ํ†ตํ•ด ์ˆœํ™˜ํ•ฉ๋‹ˆ๋‹ค

B ์„ธํฌ(B cell)๋ผ๊ณ ๋„ ๋ถˆ๋ฆฌ๋Š” B ๋ฆผํ”„๊ตฌ(B lymphocyte)๋Š” ํ˜ˆ์•ก์ด๋‚˜ ๋ฆผํ”„๊ณ„(lymph system)์˜ ๋ณ‘์›์ฒด๋ฅผ ๊ฐ์ง€ํ•ฉ๋‹ˆ๋‹ค. B ์„ธํฌ๋Š” ๊ณจ์ˆ˜(bone marrow)์—์„œ ์œ ๋ž˜ํ•˜์ง€๋งŒ, B ์„ธํฌ๋ž€ ์ด๋ฆ„์€ B ์„ธํฌ๊ฐ€ ์ฒ˜์Œ ๋ฐœ๊ฒฌ๋œ ์ƒˆ์˜ ํŠน๋ณ„ํ•œ ๊ธฐ๊ด€์ธ Fabricius์˜ ์œคํ™œ์ฃผ๋จธ๋‹ˆ(bursa)์—์„œ ์œ ๋ž˜ํ•ฉ๋‹ˆ๋‹ค. B ์„ธํฌ๋Š” ๊ณจ์ˆ˜์—์„œ ๋ฐฉ์ถœ๋œ ํ›„ ์ง€๋ผ(spleen; ๋น„์žฅ), ๋ฆผํ”„์ƒ˜(lymph node; ๋ฆผํ”„์ ˆ), ํŽธ๋„(tonsil), ์ ๋ง‰ ๊ด€๋ จ ๋ฆผํ”„ ์กฐ์ง(mucosa-associated lymphoid tissue)๊ณผ ๊ฐ™์€ 2์ฐจ ๋ฆผํ”„ ์กฐ์ง(secondary lymphoid tissue)์—์„œ ์„ฑ์ˆ™ํ•ฉ๋‹ˆ๋‹ค.

B ์„ธํฌ๋Š” ํ•ญ์ฒด๋ฅผ ๋ฐฉ์ถœํ•˜๋Š” ํ˜•์งˆ์„ธํฌ์™€ ๊ธฐ์–ต B ์„ธํฌ๋กœ ๋ถ„ํ™”ํ•ฉ๋‹ˆ๋‹ค

B ์„ธํฌ๋Š” B ์„ธํฌ ์ˆ˜์šฉ์ฒด(B cell receptor)๋ฅผ ํ†ตํ•ด ํ•ญ์›(antigen)์ด๋ผ๊ณ  ๋ถˆ๋ฆฌ๋Š” ๋ณ‘์›์ฒด์˜ ํŠน์ • ๋ถ€๋ถ„์— ๊ฒฐํ•ฉํ•ฉ๋‹ˆ๋‹ค. B ์„ธํฌ๋Š” ํ•ญ์› ๊ฒฐํ•ฉ ์™ธ์—๋„ ํ™œ์„ฑํ™”๋ฅผ ์œ„ํ•ด ๋‘ ๋ฒˆ์งธ ์‹ ํ˜ธ๊ฐ€ ํ•„์š”ํ•ฉ๋‹ˆ๋‹ค. ์ด ์‹ ํ˜ธ๋Š” ๋„์›€ T ์„ธํฌ(helper T cell)๋‚˜, ๋•Œ์— ๋”ฐ๋ผ์„œ๋Š” ํ•ญ์› ์ž์ฒด์— ์˜ํ•ด ์ œ๊ณต๋  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. B ์„ธํฌ๋Š” ๋‘ ์ž๊ทน์ด ๋ชจ๋‘ ์กด์žฌํ•  ๋•Œ ๋ฐฐ์ค‘์‹ฌ(germinal center)์„ ํ˜•์„ฑํ•ด ์ด๊ณณ์—์„œ ํ˜•์งˆ์„ธํฌ(plasma cell)์™€ ๊ธฐ์–ต B ์„ธํฌ(memory B cell)๋กœ ์ฆ์‹ํ•ฉ๋‹ˆ๋‹ค. ๊ณตํ†ต๋œ ์กฐ์ƒ B ์„ธํฌ์—์„œ ํŒŒ์ƒ๋œ ๋ชจ๋“  ์„ธํฌ(์ฆ‰ ๋‹จ์ผํด๋ก ; monoclonal)๋Š” ๋™์ผํ•œ ํ•ญ์›์— ๋ฐ˜์‘ํ•ฉ๋‹ˆ๋‹ค. ๊ฐ ํ˜•์งˆ์„ธํฌ๋Š” ํ˜ˆ๋ฅ˜์—์„œ ์ˆœํ™˜ํ•˜๋Š” ์œ ์ „์ ์œผ๋กœ ๋™์ผํ•œ ํ•ญ์ฒด๋ฅผ ๋ถ„๋น„ํ•ฉ๋‹ˆ๋‹ค. ๊ธฐ์–ต B ์„ธํฌ๋Š” ์„ธํฌ ํ‘œ๋ฉด์— ๊ฒฐํ•ฉํ•˜๋Š” ํ•ญ์ฒด๋ฅผ ์ƒ์‚ฐํ•˜๋ฉฐ, ๊ธฐ์–ต B ์„ธํฌ์˜ ์ƒ์‚ฐ์„ ์ดˆ๊ธฐ์— ์ด๋ˆ ํ•ญ์›์— ๋Œ€ํ•ด ๋งค์šฐ ํŠน์ด(specific)ํ•ฉ๋‹ˆ๋‹ค. ๊ธฐ์–ต B ์„ธํฌ๋Š” ์˜ค๋ž˜๊ฐ€๊ณ  ๊ฐ™์€ ๋ณ‘์›์ฒด์— 2์ฐจ๋กœ ๋…ธ์ถœ๋˜๋ฉด ์œ ๊ธฐ์ฒด๊ฐ€ ํ›จ์”ฌ ๋” ๋น ๋ฅด๊ณ  ๊ฐ•ํ•˜๊ฒŒ ๋ฐ˜์‘ํ•  ์ˆ˜ ์žˆ๊ฒŒ ๋งŒ๋“ญ๋‹ˆ๋‹ค.

ํ•ญ์ฒด๋Š” ๋‹ค์–‘ํ•œ ๋ฐฉ๋ฒ•์œผ๋กœ ๋ณ‘์›์ฒด๋ฅผ ์ฃฝ์ž…๋‹ˆ๋‹ค

ํ•ญ์ฒด๋Š” ์ฒด์•ก์—์„œ ๋งˆ์ฃผ์น˜๋Š” ํ•ญ์›๊ณผ ๊ฒฐํ•ฉํ•ฉ๋‹ˆ๋‹ค. ๊ทธ ๊ฒฐ๊ณผ ํ•ญ์ฒด-ํ•ญ์› ๋ณตํ•ฉ์ฒด(antibody-antigen complex)๋Š” ์ค‘ํ™”, ์˜ต์†Œ๋‹Œํ™”, ๋ณด์ฒดํ™œ์„ฑํ™”๋ผ๋Š” ์„ธ ๊ฐ€์ง€ ์ฃผ์š” ๋ฐฉ์–ด ๊ธฐ์ž‘์„ ํ™œ์„ฑํ™”ํ•ฉ๋‹ˆ๋‹ค.

์ค‘ํ™”: ํ•ญ์ฒด๋Š” ์ˆ™์ฃผ ์„ธํฌ๋ฅผ ๊ฐ์—ผ์‹œํ‚ค๋Š” ๋Šฅ๋ ฅ์„ ๋ฐฉํ•ดํ•จ์œผ๋กœ์จ ๋ณ‘์›์ฒด๋ฅผ “์ค‘ํ™”&rdquoํ•ฉ๋‹ˆ๋‹ค. ์˜ˆ๋ฅผ ๋“ค์–ด, ํ•ญ์ฒด๊ฐ€ ๋ฐ”์ด๋Ÿฌ์Šค์˜ ํ‘œ๋ฉด์— ๊ฒฐํ•ฉํ•˜๋ฉด ๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€ ํ‘œ์  ์„ธํฌ(target cell)์— ๋ถ€์ฐฉํ•˜๊ฑฐ๋‚˜ ์นจ์ž…ํ•˜๋Š” ๋Šฅ๋ ฅ์„ ์†์ƒํ•ด ๊ฐ์—ผ์„ ํšจ๊ณผ์ ์œผ๋กœ ์–ต์ œํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

์˜ต์†Œ๋‹Œํ™”: ํ•ญ์ฒด๋Š” ๋ณ‘์›์ฒด๋ฅผ ํŒŒ๊ดดํ•˜๊ธฐ ์œ„ํ•ด “๊ผฌ๋ฆฌํ‘œ”๋ฅผ ๋‹ค๋Š” ์˜ต์†Œ๋‹Œ(opsonin) ์—ญํ• ์„ ํ•ฉ๋‹ˆ๋‹ค. ๊ตฌ์ฒด์ ์œผ๋ก  ํ•ญ์›-ํ•ญ์ฒด ๋ณตํ•ฉ์ฒด์˜ ํ˜•์„ฑ์ด ๋ณ‘์›์ฒด๋ฅผ ์ง‘์–ด์‚ผํ‚ค๊ณ  ํŒŒ๊ดดํ•˜๋Š” ์‹์„ธํฌ๋ฅผ ๋Œ์–ด์˜ค๊ณ  ์ž๊ทนํ•ฉ๋‹ˆ๋‹ค.

๋ณด์ฒดํ™œ์„ฑํ™”: ํ•ญ์ฒด๋Š” ์„ ์ฒœ๋ฉด์—ญ(innate immunity)๊ณผ ์ ์‘๋ฉด์—ญ(adaptive immunity; ํ›„์ฒœ๋ฉด์—ญ) ๋ชจ๋‘์—์„œ ์—ญํ• ์„ ํ•˜๋Š” ๋ณด์ฒด๊ณ„(complement system)๋ฅผ ํ™œ์„ฑํ™”ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ๋ณด์ฒด๊ณ„๋Š” 30๊ฐœ ์ด์ƒ์˜ ๋‹จ๋ฐฑ์งˆ์˜ ์ˆœ์ฐจ์  ์—ฐ์‡„๋ฐ˜์‘(cascade)์ž…๋‹ˆ๋‹ค. ํ•ญ์ฒด์˜ ๋„์›€์œผ๋กœ, ์ด ๋‹จ๋ฐฑ์งˆ์€ ๋Œ€์‹์„ธํฌ(macrophage)์™€ ํ˜ธ์ค‘๊ตฌ(neutrophil)๊ฐ€ ํŒŒ๊ดดํ•˜๋„๋ก ๋ณ‘์›์ฒด๋ฅผ ์˜ต์†Œ๋‹Œํ™”ํ•˜๊ณ , ๋ฉด์—ญ์„ธํฌ์˜ ์ถ”๊ฐ€ ๋ชจ์ง‘๊ณผ ํ•จ๊ป˜ ์—ผ์ฆ ๋ฐ˜์‘์„ ์œ ๋„ํ•˜๊ณ , ๋ณ‘์›์ฒด์˜ ์šฉํ•ด(lysis)๋ฅผ ์ด‰์ง„ํ•ฉ๋‹ˆ๋‹ค.

์ฒด์•ก์„ฑ ๋ฉด์—ญ ์ฒด๊ณ„์˜ ์ค‘๋‹จ์€ ์ƒ๋ช…์„ ์œ„ํ˜‘ํ•ฉ๋‹ˆ๋‹ค

์ฒด์•ก์„ฑ ๋ฉด์—ญ ์งˆํ™˜์€ ๋Œ€๊ฐœ ์œ ์•„๊ฐ€ ์‚ฐ๋ถ€์—๊ฒŒ ๋ฐ›์€ ํ•ญ์ฒด(์ฆ‰, ์ˆ˜๋™๋ฉด์—ญ(passive immunity))์˜ ์ˆ˜๊ฐ€ ๊ฐ์†Œํ•˜๋Š” ์ƒ์˜ ์ดˆ๋ฐ˜์— ๋ฐœ๊ฒฌ๋ฉ๋‹ˆ๋‹ค. ์ฒด์•ก์„ฑ ๋ฉด์—ญ ์ฒด๊ณ„๊ฐ€ ๋ณต์žกํ•˜๋‹ค๋Š” ์ ์„ ๊ณ ๋ คํ•  ๋•Œ, ๊ธฐ๋Šฅ ๋ถ€์ „์˜ ์›์ธ์€ ๋‹ค์–‘ํ•ฉ๋‹ˆ๋‹ค. 1์ฐจ ๋ฉด์—ญ ๊ฒฐํ•์ฆ(primary immunodeficiency disease)์„ ์•“๊ณ  ์žˆ๋Š” ํ™˜์ž๋Š” ๊ฑฐ์˜ 80%๊ฐ€ ํ•ญ์ฒด ์žฅ์• ๋ฅผ ๊ฐ€์ง€๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. ์˜ˆ๋ฅผ ๋“ค์–ด, ์ €๊ฐ๋งˆ๊ธ€๋กœ๋ถˆ๋ฆฐํ˜ˆ์ฆ(hypogammaglobulinemia)์—์„  ๋ชจ๋“  ์ข…๋ฅ˜์˜ ํ•ญ์ฒด๊ฐ€ ๊ฒฐํ• ๋˜๋Š” ๋‚ฎ์€ ์ˆ˜์น˜๋กœ ์กด์žฌํ•ฉ๋‹ˆ๋‹ค. ์ €๊ฐ๋งˆ๊ธ€๋กœ๋ถˆ๋ฆฐํ˜ˆ์ฆ ํ™˜์ž๋Š” ๊ท€, ๋ถ€๋น„๊ฐ•(sinus), ํ—ˆํŒŒ ๊ฐ์—ผ์ด ์žฆ๊ณ  ์„ค์‚ฌ, ํก์ˆ˜์žฅ์• , ๊ณผ๋ฏผ์„ฑ ์žฅ์ฆํ›„๊ตฐ(irritable bowel syndrome) ๋“ฑ์˜ ์œ„์žฅ ๋ฌธ์ œ๋ฅผ ๊ฒช์Šต๋‹ˆ๋‹ค. ์ผ๋ฐ˜์ ์œผ๋กœ ํ™˜์ž ๊ฐ์—ผ์˜ ๋นˆ๋„์™€ ์‹ฌ๊ฐ๋„๋Š” ๋‚˜์ด๊ฐ€ ๋“ค์ˆ˜๋ก ์ฆ๊ฐ€ํ•ฉ๋‹ˆ๋‹ค. ํ”์น˜ ์•Š์€ ๋ณ‘์›์ฒด์— ์˜ํ•œ ๊ฐ์—ผ์€ ์‹ฌ๊ฐํ•œ ๊ฒฝํ–ฅ์ด ์žˆ๊ณ , ํ”ํ•œ ๋ณ‘์›์ฒด์— ์˜ํ•œ ๊ฐ์—ผ์€ ์ข…์ข… ์‹ฌ๊ฐํ•˜๊ธฐ๋„ ํ•˜๊ณ  ์žฌ๋ฐœํ•˜๊ธฐ๋„ ํ•ฉ๋‹ˆ๋‹ค.

Suggested Reading

Dunkelberger, Jason R., and Wen-Chao Song. “Complement and Its Role in Innate and Adaptive Immune Responses.” Cell Research 20, no. 1 (January 2010): 34–50. [Source]